Am J Perinatol 2005; 22(8): 413-419
DOI: 10.1055/s-2005-872592
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Neonatal Hepatoblastoma: Two Cases Posing a Diagnostic Dilemma, with a Review of the Literature

Adel Sallam1 , Bosco Paes2 , Jacqueline Bourgeois3
  • 1Neonatal/Perinatal Medicine Programme, McMaster University, Hamilton, Ontario, Canada
  • 2Professor of Pediatrics (Neonatal Division), McMaster University, Hamilton, Ontario, Canada
  • 3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Further Information

Publication History

Publication Date:
17 September 2005 (online)

ABSTRACT

Hepatoblastoma accounts for less than 1% of all pediatric malignancies. However, it remains the most common malignant tumor of the liver in newborns. Less than 10% of hepatoblastoma cases are diagnosed in the neonatal period. The diagnosis can be very difficult due to the wide spectrum of presentation and differences in the size of the lesion at the time of detection either antenatally or during an infant’s neonatal course. In this review, we describe the current investigations used to establish the diagnosis of congenital hepatoblastoma and the role of a nuclear red cell scan as an additional strategy in the evaluation of this malignant condition. The report uses two cases of neonatal hepatoblastoma to highlight both the clinical and pathologic findings, and the problems encountered in the evaluation of this disorder.

REFERENCES

  • 1 Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y. Development of unfavourable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review.  Cancer. 1998;  82 1789-1796
  • 2 Tanimura M, Matsui I, Abe J et al.. Increased risk of hepatoblastoma among immature children with a lower birth weight.  Cancer Res. 1998;  58 3032-3035
  • 3 Reynolds P, Urayama K Y, Von Behren J, Feusner J. Birth characteristics and hepatoblastoma risk in young children.  Cancer. 2004;  100 1070-1076
  • 4 Maruyama K, Ikeda H, Koizumi T et al.. Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight.  Pediatr Int. 2000;  42 492-498
  • 5 Orozco-Florian R, McBride J A, Favara B E, Steele A, Brown S J, Steele P. Congenital hepatoblastoma and Beckwith-Wiedemann syndrome: a case study including DNA ploidy profiles of tumor and adrenal cytomegaly.  Pediatr Pathol. 1991;  11 131-142
  • 6 Mamlok V, Nichols M, Lockhart L, Mamlok R. Trisomy 18 and hepatoblastoma.  Am J Med Genet. 1989;  33 125-126
  • 7 Khan A, Bader J L, Hoy G R, Sinks L F. Hepatoblastoma in child with fetal alcohol syndrome.  Lancet. 1979;  1 1403-1404
  • 8 Giardullo F M, Offerhaus G J, Krush A J et al.. Risk of hepatoblastoma in familial adenomatous polyposis.  J Pediatr. 1991;  119 766-768
  • 9 Isaacs H. Tumors of the Fetus and Newborn. Philadelphia; W.B. Saunders 1997
  • 10 von Schweinitz D. Neonatal liver tumours.  Semin Neonatol. 2003;  8 403-410
  • 11 Ammann R A, Plaschkes J, Leibundgut K. Congenital hepatoblastoma: a distinct entity?.  Med Pediatr Oncol. 1999;  32 466-468
  • 12 Endo E G, Walton D S, Albert D M. Neonatal hepatoblastoma metastatic to the choroids and iris.  Arch Ophthalmol. 1996;  114 757-761
  • 13 Kazzi N J, Chang C H, Roberts E C, Shankaran S. Fetal hepatoblastoma presenting as nonimmune hydrops.  Am J Perinatol. 1989;  6 278-280
  • 14 Tanaka T, Takakura H, Takashima S, Kodama T, Hasegawa H. A rare case of Aicardi syndrome with severe brain malformation and hepatoblastoma.  Brain Dev. 1985;  7 507-512
  • 15 Nagata T, Takahashi Y, Ishii Y et al.. Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array.  Cancer Genet Cytogenet. 2003;  145 152-160
  • 16 Buckley J D, Sather H, Ruccione K et al.. A case-control study of risk factors for hepatoblastoma: a report from the Childrens Cancer Study Group.  Cancer. 1989;  64 1169-1176
  • 17 Pang D, McNally R, Birch J M. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study.  Br J Cancer. 2003;  88 373-381
  • 18 Shih J C, Tsao P N, Huang S F et al.. Antenatal diagnosis of congenital hepatoblastoma in utero.  Ultrasound Obstet Gynecol. 2000;  16 94-97
  • 19 Sirota L, Freud N, Dulitzki F et al.. Hemoperitoneum as the presenting sign of hepatoblastoma in a newborn.  Pediatr Surg Int. 1992;  7 131-133
  • 20 Clericuzio C L, Chen E, McNeil D E et al.. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.  J Pediatr. 2003;  143 270-272
  • 21 Everman D B, Shuman C, Dzolganovski B, O’Riordan M A, Weksberg R, Robin N H. Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome.  J Pediatr. 2000;  137 123-127
  • 22 Blohm M E, Vesterling-Horner D, Calaminus G, Gobel U. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age.  Pediatr Hematol Oncol. 1998;  15 135-142
  • 23 Lahdenne P, Kuusela P, Siimes M A, Ronnholm K A, Salmenpera L, Heikinheimo M. Biphasic reduction and concanavalin: a binding properties of serum alpha-fetoprotein in preterm and term infants.  J Pediatr. 1991;  118 272-276
  • 24 von Schweinitz D, Gluer S, Mildenberger H. Liver tumors in neonates and very young infants: diagnostic pitfalls and therapeutic problems.  Eur J Pediatr Surg. 1995;  5 72-76
  • 25 Dachman A H, Pakter R L, Ros P R, Fishman E K, Goodman Z D, Lichtenstein J E. Hepatoblastoma: radiologic-pathologic correlation in 50 cases.  Radiology. 1987;  164 15-19
  • 26 Klein M A, Slovis T L, Chang C H, Jacobs I G. Sonographic and Doppler features of infantile hepatic hemangiomas with pathologic correlation.  J Ultrasound Med. 1990;  9 619-624
  • 27 Ingram J D, Yerushalmi B, Connell J, Karrer F M, Tyson R W, Sokol R J. Hepatoblastoma in a neonate: a hypervascular presentation mimicking hemangioendothelioma.  Pediatr Radiol. 2000;  30 794-797
  • 28 Szavay P O, Wermes C, Fuchs J, Schrappe M, Flemming P, von Schweinitz D. Effective treatment of infantile choriocarcinoma in the liver with chemotherapy and surgical resection: a case report.  J Pediatr Surg. 2000;  35 1134-1135
  • 29 Boechat M I, Kangarloo H, Ortega J et al.. Primary liver tumors in children: comparison of CT and MR imaging.  Radiology. 1988;  169 727-732
  • 30 Park C H, Hwang H S, Hong J, Pak M S. Giant infantile hemangioendothelioma of the liver scintigraphic diagnosis.  Clin Nucl Med. 1996;  21 293-295
  • 31 Miller J H. Technetium-99m-labeled red blood cells in the evaluation of hemangiomas of the liver in infants and children.  J Nucl Med. 1987;  28 1412-1418
  • 32 Sloan G M, Bolton L L, Miller J H, Reinisch J F, Nichter L S. Radionuclide-labeled red blood cell imaging of vascular malformations in children.  Ann Plast Surg. 1988;  21 236-241
  • 33 Haas J E, Muczynski K A, Krailo M et al.. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma.  Cancer. 1989;  64 1082-1095
  • 34 Men S, Hekimoglu B, Tuzin M, Arda I S, Pmar A. Unusual US and CT findings in the hepatoblastoma: a case report.  Pediatr Radiol. 1995;  25 507-508

Bosco PaesM.D. 

Department of Pediatrics, Room 4G40, McMaster University

1200 Main Street West, Hamilton, Ontario, Canada L8S 4J9

    >